Gilead Sciences : GILD

All Gilead Sciences Articles

736 Articles

Douglas A. McIntyre | Dec 30, 2009 at 8:19 AM EST

Top Analyst Upgrades and Downgrades (AAPL, ARCL, GILD, GTEC, MRVL, NVDA)

This Wednesday is looking thinner than normal trading days for analyst upgrades and downgrades seen in Wall Street research calls. …

Douglas A. McIntyre | Dec 15, 2009 at 8:31 AM EST

Top Day Trader Alerts (WFC, JASO, LIMS, ARRY, GILD)

This morning’s top day trader and active trader alerts are below with links to VSInvestor.com on each stock story with…

Douglas A. McIntyre | Sep 2, 2009 at 8:21 AM EDT

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

These are the top ten analyst research initiations, upgrades, and downgrades we have seen from top Wall Street firms early…

Douglas A. McIntyre | Jul 22, 2009 at 7:53 AM EDT

Top Day Trader Alerts (CIT, ONXX, HGSI, WINN, OFG, AAPL, AMD, YHOO, SBUX, AMLN, GILD)

The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

Douglas A. McIntyre | Jul 13, 2009 at 10:25 AM EDT

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed…

Douglas A. McIntyre | Jun 25, 2009 at 11:31 AM EDT

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early…

Douglas A. McIntyre | Apr 27, 2009 at 6:40 AM EDT

Swine Flu Lessons from SARS, Mad Cow & Bird Flu of Past (GILD, BCRX, NVAX, GNBT, VICL, AVII, CRXL, RHHBY, GSK, SFD, EWW, MXF)

Monday is looking like a SWINE FLU speculative flu stock stock bonanza, and we want to caution about some of…

Douglas A. McIntyre | Mar 12, 2009 at 8:10 AM EDT

Gilead Wins CV Therapeutics Bid; Higher Bid Coming? (GILD, CVTX)

Gilead Sciences, Inc. (Nasdaq: GILD) has agreed to buy CV Therapeutics, Inc. (Nasdaq: CVTX) for $20.00 per share in cash.

Douglas A. McIntyre | Feb 5, 2009 at 5:57 PM EST

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know…

Douglas A. McIntyre | Jan 5, 2009 at 7:15 AM EST

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT…

Douglas A. McIntyre | Dec 23, 2008 at 7:38 AM EST

Top Analyst Upgrades & Downgrades (ACM, AXYS, CTAS, CVD, GILD, PPDI, VISN, EPG, VTIV)

It is getting pretty thin in major analyst coverage as firms are encouraged to go easy on major year-end calls…

Douglas A. McIntyre | Dec 15, 2008 at 7:52 AM EST

Top Pre-Market Analyst Upgrades (MO, BBY, CFL, CEPH, GILD, LMT, TNDM, NOC, TLAB, MTN)

These are the top pre-market upgrades and positive analyst calls we have seen from Wall Street this Monday morning: Altria…

Douglas A. McIntyre | Dec 10, 2008 at 11:04 AM EST

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally…

Douglas A. McIntyre | Oct 16, 2008 at 3:23 PM EDT

Gilead Boosted Partly By Currencies (GILD)

Gilead Sciences Inc. (NASDAQ: GILD) has just issued its third quarter earnings at $0.52 net EPS and $0.55 non-GAAP EPS…

1 … 46 47 48 49 50

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades and Downgrades (AAPL, ARCL, GILD, GTEC, MRVL, NVDA)

Top Day Trader Alerts (WFC, JASO, LIMS, ARRY, GILD)

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

Top Day Trader Alerts (CIT, ONXX, HGSI, WINN, OFG, AAPL, AMD, YHOO, SBUX, AMLN, GILD)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Swine Flu Lessons from SARS, Mad Cow & Bird Flu of Past (GILD, BCRX, NVAX, GNBT, VICL, AVII, CRXL, RHHBY, GSK, SFD, EWW, MXF)

Gilead Wins CV Therapeutics Bid; Higher Bid Coming? (GILD, CVTX)

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Top Analyst Upgrades & Downgrades (ACM, AXYS, CTAS, CVD, GILD, PPDI, VISN, EPG, VTIV)

Top Pre-Market Analyst Upgrades (MO, BBY, CFL, CEPH, GILD, LMT, TNDM, NOC, TLAB, MTN)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

Gilead Boosted Partly By Currencies (GILD)

$500,000 and One Income ETF Slot: Which of SPYI, JEPQ and GPIQ Holds Up in a Dead Quiet Market?

Meta Facing $1.4 Trillion in Damages: Inside the Trial That Could Redefine Big Tech

3 High Yield Mortgage REITs Running Very Different Playbooks

Retirees Are Rooting for a Big 2027 COLA. A Large One Means Higher Medicare Premiums and a Bigger Tax Bill

Yelp's Chairman Used Under-the-Radar Roth Strategy to Get $95 Million Into His Account, And He Will Never Pay Another Dollar Of Tax On That Money. The Same Tax Rules Apply To You

$500,000 and One Income ETF Slot: Which of SPYI, JEPQ and GPIQ Holds Up in a Dead Quiet Market?

Meta Facing $1.4 Trillion in Damages: Inside the Trial That Could Redefine Big Tech

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades and Downgrades (AAPL, ARCL, GILD, GTEC, MRVL, NVDA)

Top Day Trader Alerts (WFC, JASO, LIMS, ARRY, GILD)

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

Top Day Trader Alerts (CIT, ONXX, HGSI, WINN, OFG, AAPL, AMD, YHOO, SBUX, AMLN, GILD)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Swine Flu Lessons from SARS, Mad Cow & Bird Flu of Past (GILD, BCRX, NVAX, GNBT, VICL, AVII, CRXL, RHHBY, GSK, SFD, EWW, MXF)

Gilead Wins CV Therapeutics Bid; Higher Bid Coming? (GILD, CVTX)

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Top Analyst Upgrades & Downgrades (ACM, AXYS, CTAS, CVD, GILD, PPDI, VISN, EPG, VTIV)

Top Pre-Market Analyst Upgrades (MO, BBY, CFL, CEPH, GILD, LMT, TNDM, NOC, TLAB, MTN)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

Gilead Boosted Partly By Currencies (GILD)

$500,000 and One Income ETF Slot: Which of SPYI, JEPQ and GPIQ Holds Up in a Dead Quiet Market?

Meta Facing $1.4 Trillion in Damages: Inside the Trial That Could Redefine Big Tech

3 High Yield Mortgage REITs Running Very Different Playbooks

Featured Reads

Retirees Are Rooting for a Big 2027 COLA. A Large One Means Higher Medicare Premiums and a Bigger Tax Bill

Yelp's Chairman Used Under-the-Radar Roth Strategy to Get $95 Million Into His Account, And He Will Never Pay Another Dollar Of Tax On That Money. The Same Tax Rules Apply To You